Gene · 5106
Papers3,204
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,204
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Potential Benefits of Antioxidant Phytochemicals in Type 2 Diabetes. | Molecules | 2023 | 37894687 | PubTator, text mining | PubMed |
| China Medicinal Plants of the Ampelopsis grossedentata-A Review of Their Botanical Characteristics, Use, Phytochemistry, Active Pharmacological Components, and Toxicology. | Molecules | 2023 | 37894624 | PubTator, text mining | PubMed |
| Breast Cancer Molecular Subtypes Differentially Express Gluconeogenic Rate-Limiting Enzymes-Obesity as a Crucial Player. | Cancers (Basel) | 2023 | 37894303 | PubTator, text mining | PubMed |
| Harnessing Oleanolic Acid and Its Derivatives as Modulators of Metabolic Nuclear Receptors. | Biomolecules | 2023 | 37892147 | PubTator, text mining | PubMed |
| Allosteric regulation of the lid domain of PCK2 as a novel strategy for modulating mitochondrial dynamics. | Chem Commun (Camb) | 2023 | 37885376 | PubTator, text mining | PubMed |
| Identification of subclusters and prognostic genes based on glycolysis/gluconeogenesis in hepatocellular carcinoma. | Front Immunol | 2023 | 37881434 | PubTator, text mining | PubMed |
| Mutant p53 sustains serine-glycine synthesis and essential amino acids intake promoting breast cancer growth. | Nat Commun | 2023 | 37880212 | PubTator, text mining | PubMed |
| Antitumor Effects of PRMT5 Inhibition in Sarcomas. | Cancer Res Commun | 2023 | 37861293 | PubTator, text mining | PubMed |
| Insulin Receptor Isoforms and Insulin Growth Factor-like Receptors: Implications in Cell Signaling, Carcinogenesis, and Chemoresistance. | Int J Mol Sci | 2023 | 37834454 | PubTator, text mining | PubMed |
| Meta-analysis of lean and obese RNA-seq datasets to identify genes targeting obesity. | Bioinformation | 2023 | 37808366 | PubTator, text mining | PubMed |
| Comparative study of the mechanism of natural compounds with similar structures using docking and transcriptome data for improving in silico herbal medicine experimentations. | Brief Bioinform | 2023 | 37798251 | PubTator, text mining | PubMed |
| Exploring the mechanism of metformin action in Alzheimer's disease and type 2 diabetes based on network pharmacology, molecular docking, and molecular dynamic simulation. | Ther Adv Endocrinol Metab | 2023 | 37780174 | PubTator, text mining | PubMed |
| Sesamol Alleviates High-Fat Diet-Induced Hepatic Insulin Resistance in C57BL/6 J Mice Through AMPK Activation Mediated by Adipose Adiponectin. | Plant Foods Hum Nutr | 2023 | 37775709 | PubTator, text mining | PubMed |
| Non-alcoholic fatty liver disease in women - Current knowledge and emerging concepts. | JHEP Rep | 2023 | 37771547 | PubTator, text mining | PubMed |
| Characteristics of insulin resistance in Korean adults from the perspective of circadian and metabolic sensing genes. | Genes Genomics | 2023 | 37768516 | PubTator, text mining | PubMed |
| Host and HBV Interactions and Their Potential Impact on Clinical Outcomes. | Pathogens | 2023 | 37764954 | PubTator, text mining | PubMed |
| Aspartic Acid in Health and Disease. | Nutrients | 2023 | 37764806 | PubTator, text mining | PubMed |
| Theabrownin from Dark Tea Ameliorates Insulin Resistance via Attenuating Oxidative Stress and Modulating IRS-1/PI3K/Akt Pathway in HepG2 Cells. | Nutrients | 2023 | 37764646 | PubTator, text mining | PubMed |
| Ochratoxin A-The Current Knowledge Concerning Hepatotoxicity, Mode of Action and Possible Prevention. | Molecules | 2023 | 37764392 | PubTator, text mining | PubMed |
| Recent Insights into the Biomarkers, Molecular Targets and Mechanisms of Non-Alcoholic Steatohepatitis-Driven Hepatocarcinogenesis. | Cancers (Basel) | 2023 | 37760534 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5106/papers?page=13